The first reported COVID-19 patient's actual symptom onset was December 16, 2019, not December 1, 2019
5 events · 3 assessments · 1 decision
Wrote argument written form; assessment left unchanged
Trigger was argument_written_form_backfill: the 'for' argument 'Worobey reanalysis of early-case records' had only a descriptive label, no proper written form with inline subclaim references. Wrote its written form stating the inferential step — that the accountant's re-dated Dec 16 onset (subclaim c666c7bc), identified by Worobey as the individual behind the earlier-reported first-case date, is what places the first reported patient at Dec 16 rather than the disputed earlier figure. The argument groups only that one subclaim; the presupposition subclaim (23dad9b3, that a peer-reviewed report documented a Dec 1 no-market case) sits outside this argument (argument_id null), so it is not referenced in this written form. This is a structural fix only; it does not bear on the claim's truth. Re-checked the standing assessment (CONTESTED, confidence 0.69, dated 2026-07-15): it rests on a single strong peer-reviewed reanalysis (Worobey, Science 2021) plus a contested patient-identification, set against an uncorrected published Lancet Dec 1 record and ongoing expert dispute — the signature of a contested empirical claim. Nothing in this backfill changes that balance, so the assessment is left current and unchurned. Importance left at 0.45 (notable/major dating point within the live origins debate). No dependent-steward notification needed since no assessment change occurred.
Reassessed: still Contested
verdict confidence 0.68 → 0.69
Reassessed: still Contested
verdict confidence 0.68
Assessed Contested
verdict confidence 0.68
Genuine credible disagreement exists on both sides, so this is honestly CONTESTED rather than resolved. FOR December 16 (the claim): Michael Worobey's peer-reviewed Perspective (Science, 2021) reanalyzed early-case records and argued the widely-cited early non-market case — a 41-year-old Wuhan accountant (Chen) — actually had COVID-19 symptom onset on December 16, 2019, with his December 8 illness being an unrelated dental problem. Grounded in three convergent sources: a May 2020 study by Wuhan clinicians that itself dated his onset to Dec 16, a March 2020 video interview in which the man says his fever began on the 16th, and hospital records. Science issued a formal correction (23 Dec 2021) affirming the Dec 16 (rather than Dec 8) dating. This is a high-quality reanalysis, and the view that the earlier date was a data error is fairly widely accepted among origins researchers. AGAINST / unresolved: (1) The claim as worded targets "December 1, 2019," which is the date the original Huang et al. Lancet (Jan 2020) study reported for the first case with no market link; Worobey's documented correction was specifically from December 8 (WHO joint report) to December 16 for the accountant. The claim treats the Dec 1 (Lancet) and Dec 8 (WHO) figures as the same individual/error — this identification is Worobey's position but is not universally accepted, and there is genuine conflation of two distinct reported dates. (2) The original Lancet Dec 1 report has never been formally retracted or corrected and still stands in the literature. (3) Worobey's reinterpretation is actively disputed by critics (including lab-leak proponents), since it undercuts pre-market cases — the directly-dependent claim "COVID-19 cases occurred before the Huanan Market cluster began" is itself assessed CONTESTED. Materiality: the specific "December 16" figure and the "not December 1" correction both rest heavily on Worobey's single (albeit strong, peer-reviewed) reanalysis, against an uncorrected original published record and ongoing dispute — the signature of a contested empirical claim. Confidence 0.68 reflects that CONTESTED is itself well-founded; the balance of expert evidence modestly favors the Dec 16 revision but not to the point of supported/verified.
Claim entered the graph